Aktie NORTHWEST BIOTHERAPEUTICS, INC
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Northwest Biotherapeutics, Inc OTC Bulletin Board

Aktien

US66737P5017

Schlusskurs OTC Bulletin Board
Andere Börsenplätze
- USD - Intraday Chart für Northwest Biotherapeutics, Inc
10.05. Northwest Biotherapeutics, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
21.03. Northwest Biotherapeutics, Inc. ernennt Pat Sarma zum Mitglied des Verwaltungsrats CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property
Northwest Biotherapeutics: Q1 Earnings Snapshot
Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors
Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification
Northwest Biotherapeutics announces that a Marketing Authorization Application has been submitted to the UK MHRA for DCVax-L for Glioblastoma
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma
Northwest Biotherapeutics Announces Marketing Authorization Application Has Been Submitted to the UK MHRA for DCVax-L for Glioblastoma
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Northwest Biotherapeutics, Inc. announced that it has received $11.005 million in funding from Streeterville Capital, LLC
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Today's Top Nano-Cap Stock Watchlist (MGUY, AABB, NWBO, ICU)
Northwest Biotherapeutics Provides Update on Near Term Plans for Submission of Marketing Authorization Application
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application
Companies Spotlighted on "The Street Reports Podcast" Unveiling Secrets to Success: CLNV, HNRC, NWBO, ASRE
Penny Stock Momentum List (ATVK, ELTP, NWBO, ENZC)
Penny Stocks Set To Soar On News Watchlist (TBRIF, NWBO, IQST, TLOFF)
Today's OTC Momentum Watchlist (RGGI, DLOC, NWBO, HMBL)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1J5EY Aktie
  4. Aktie
  5. Nachrichten Northwest Biotherapeutics, Inc
  6. Andere Sprachen